SnapChole
Acute calculous cholecystitis
Rationale
SnapChole is a prospective multicenter platform in acute calculous cholecystitis that characterizes diagnostic pathway, index management strategy, definitive source control, and 90-day downstream biliary utilization under real-world conditions.
Design
International, multicenter, time-bound prospective observational cohort study using standardized snapshot methodology and routinely collected clinical data.
Eligibility
Adults presenting for acute care with protocol-defined acute calculous cholecystitis. Exclusions include acute acalculous cholecystitis, primary gallstone pancreatitis, primary choledocholithiasis, acute cholangitis, and elective chronic biliary admissions.
Time zero
The first documented definitive disposition decision after completion of the initial diagnostic workup for suspected acute calculous cholecystitis.
Treatment strategies
- Discharge without definitive source control
- Inpatient non-operative management with interval intent
- Index-admission cholecystectomy
- Gallbladder drainage
Outcomes
Primary outcome: 90-day unplanned biliary acute-care utilization. Secondary outcomes include recurrent biliary presentation, urgent intervention, readmission, length of stay, mortality, and definitive source control by discharge.
Embedded causal questions
The platform supports restricted comparative analyses of pathway assignment and source-control strategy in clinically coherent subgroups using explicit estimands and aligned time zero.
Governance and outputs
CESOR-coordinated multicenter platform with protocol-based site onboarding and standardized public reporting. ClinicalTrials.gov registration: NCT07568080. See Outputs for methodologic and platform-linked publications, or open the dedicated SnapChole study page.